Pharmaceutical Sector in Ireland Faces Tariff and Supply Risks
Industry navigates global shifts in manufacturing
Ireland’s pharmaceutical sector is at a crossroads as it braces for the potential impact of U.S. tariffs and global supply chain disruptions.
Industry leaders warn that the challenges could reshape Ireland’s role as a major hub for drug manufacturing, forcing companies to adapt to shifting trade and regulatory pressures.
Industry leaders warn that the challenges could reshape Ireland’s role as a major hub for drug manufacturing, forcing companies to adapt to shifting trade and regulatory pressures.
